Group 1 - Shanghai Mixine Pharmaceutical Technology Development Co., Ltd. has been established with a registered capital of 10 million yuan [1] - The company is wholly owned by *ST Sailong, indicating a potential strategic alignment or investment focus [1] - The business scope includes a variety of services such as technology development, medical research, food sales, and the production and sales of medical devices [1] Group 2 - The company is authorized to engage in the production and wholesale of pharmaceuticals, as well as the import and export of drugs [1] - The operational activities are subject to approval from relevant authorities, ensuring compliance with regulatory standards [1] - The company’s activities also encompass market research, marketing planning, and various consulting services [1]
*ST赛隆成立上海觅烯医药科技发展有限公司
Zheng Quan Zhi Xing·2025-07-31 00:36